review

New Vitality, New Momentum: Xi’an’s 2025 Economic Review and Future Growth Prospects

Charting Xi'an's 2026 Vision: Driving Innovation-Led Transformation and High-Quality Development in Western ChinaXI'AN, China, March 10, 2026 /PRNewswire/ -- As…

1 week ago

International Fleet Review 2026 to Showcase India’s Naval Diplomacy and Maritime Partnerships

The Indian Navy is set to host the International Fleet Review 2026 (IFR) at VisakhapatnamVISAKHAPATNAM, India , Feb. 5, 2026 /PRNewswire/…

1 month ago

HTX Ventures Annual Review and Outlook: Regulatory Clarity, Asset Tokenization, and Institutional Adoption Resonate

PANAMA CITY, Jan. 28, 2026 /PRNewswire/ -- Recently, HTX Ventures, the global investment arm of HTX, released its latest research…

2 months ago

FDA Accepts LEQEMBI IQLIK (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease under Priority Review

If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and…

2 months ago

HTX’s 2025 Listing Strategy Review, Building a High-Liquidity Ecosystem Through First-Mover Advantage and Longtermism

PANAMA CITY, Jan. 23, 2026 /PRNewswire/ -- In 2025, persistent macro uncertainty and rapidly shifting crypto narratives turned asset selection…

2 months ago

KuCoin Releases 2025 Annual Review: A Renewed Brand, a Year Built on Trust

PROVIDENCIALES, Turks and Caicos Islands, Dec. 30, 2025 /PRNewswire/ -- KuCoin today released its 2025 Annual Review, titled "A Renewed…

3 months ago

Charles Winslow Completes Annual Internal Strategic Review at Lumena Intelligent Alliance Office

Jersey City, NJ, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Lumena Intelligent Alliance Office confirmed that Charles Winslow has completed the…

3 months ago

2025 in Review: Celebrating Each Trader’s Unique Journey on Bybit

DUBAI, UAE, Dec. 11, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is pleased to announce…

3 months ago

Genmab to Hold 2025 R&D Update and ASH Data Review Meeting

Media Release Event to be held virtually via live webcast and archived on www.genmab.com Copenhagen, Denmark; December 11, 2025 – Genmab…

3 months ago

Ascendis Announces Extension of FDA Review Period for TransCon CNP (navepegritide) for Children with Achondroplasia

November 25, 2025 18:15 ET  | Source: Ascendis Pharma –  Prescription Drug User Fee Act (PDUFA) goal date extended by…

4 months ago